Starling Oncology Inc. Wt Stock Analysis & AI Score
Starling Oncology Inc. Wt (STLNW) has an ST Score of 46.2 (C+), driven by its Growth (A-) and held back by its Momentum (D+). STLNW last traded at $0.05.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Starling Oncology Inc. Wt (STLNW) has an ST Score of 46.2 (C+), driven by its Growth (A-) and held back by its Momentum (D+). STLNW last traded at $0.05.
- Strongest
- GrowthA-
- Weakest
- MomentumD+
All factor grades
- GrowthA-
- ValuationB
- Financial StrengthC
- ProfitabilityD+
- MomentumD+
Contact
STLNW stock: frequently asked questions
What is STLNW's ST Score?
Starling Oncology Inc. Wt (STLNW) has an ST Score of 46.2 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is STLNW a buy, hold, or sell?
Our ST Score grades it C+ (46.2/100). The ST Score is a data-driven signal, not a recommendation.
What are STLNW's factor grades?
Valuation B, Profitability D+, Financial Strength C, Momentum D+, Growth A-.
What is STLNW's valuation grade?
Starling Oncology Inc. Wt (STLNW) earns a valuation grade of B, measured against Medical - Care Facilities peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is STLNW's growth grade?
Starling Oncology Inc. Wt (STLNW) earns a growth grade of A-, measured against Medical - Care Facilities peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is STLNW's profitability grade?
Starling Oncology Inc. Wt (STLNW) earns a profitability grade of D+, measured against Medical - Care Facilities peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is STLNW's financial strength grade?
Starling Oncology Inc. Wt (STLNW) earns a financial strength grade of C, measured against Medical - Care Facilities peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.